Previous Article | Next Article 
Journal of Clinical Microbiology, September 2001, p. 3356-3359, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3356-3359.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Isolation and Characterization of a Species-Specific DNA Fragment
for Identification of Candida (Torulopsis)
glabrata by PCR
Karsten
Becker,1,*
Dörte
Badehorn,1
Birgit
Keller,2
Martina
Schulte,1
Karl Heinz
Böhm,2
Georg
Peters,1 and
Wolfgang
Fegeler1
Institute of Medical Microbiology, University
of Münster, D-48149 Münster,1 and
Department of Microbiology and Infectious Diseases, School of
Veterinary Medicine, D-30173 Hannover,2
Germany
Received 9 February 2001/Returned for modification 9 May
2001/Accepted 14 June 2001
 |
ABSTRACT |
A PCR specific for Candida glabrata that amplifies a
mitochondrial rRNA gene fragment was developed by analysis of C. glabrata-specific agarose gel bands, which were generated by
arbitrarily primed PCR. The expected PCR product was successfully
amplified with genomic DNA from 95 C. glabrata isolates but
not from a number of other fungal isolates.
 |
TEXT |
In recent years, distinct shifts in
the distribution of Candida species resulting in an increase
in hospital-acquired infections due to Candida (Torulopsis)
glabrata and Candida species other than
C. albicans have been reported (17, 21, 23). In
addition, C. glabrata and other emerging yeasts are often
innately resistant to antifungal agents, specifically the azoles
(9, 24). Since conventional phenotyping systems for yeasts
may be unreliable in the identification of C. glabrata and
the conventional cultivation and diagnosis of yeasts by morphologic and
biochemical techniques require a minimum of 2 to 3 days, there is
an obvious need to introduce modern molecular methods for fast and
specific identification of this yeast species (4, 16).
Although arbitrarily primed PCR (AP-PCR) was developed primarily for
genotyping purposes, random-primer-based applications for the
identification of microorganisms have been described (5, 7,
22). The applicability of AP-PCR, however, is hampered
fundamentally by nonstringent conditions. To establish a
conventional PCR based on stringent reaction conditions, knowing the
target gene sequences is necessary. In an attempt to design specific
oligonucleotide primers for the detection of C. glabrata by
conventional PCR, AP-PCR-derived agarose gel electrophoresis patterns
of different C. glabrata genotypes were analyzed and compared with the patterns of other yeast species. Bands covering all
C. glabrata genotypes, but absent in patterns of other
Candida species, were selected for further analyses.
Subsequently, the DNA from these bands was isolated and sequenced
directly. From these sequences, putative C. glabrata-specific PCR primer pairs were designed and tested for
sensitivity and specificity on a large panel of C. glabrata
and other fungal isolates.
Fungal strains and DNA extraction.
The fungal isolates were
maintained on Kimmig's agar (Merck, Darmstadt, Germany) supplemented
with 0.1 g of chloramphenicol per liter and 0.1 g of
tetracycline per liter. All Candida isolates were tested in
their anamorphic form. The test isolates were identified by use of the
ID 32 C identification system for yeasts (bioMérieux, Marcy-l'Etoile, France) and were confirmed by standard taxonomic procedures (1, 18). Nucleic acid (NA) extracts were
prepared from 10 ml of an 18-h culture in yeast extract-peptone-glucose broth with shaking at 37°C. Yeast cells were pelleted by
centrifugation at 5,000 × g for 10 min, resuspended in
600 µl of sorbitol buffer with 200 U of lyticase, and incubated at
30°C for 0.5 h. Spheroplasts were centrifuged at
5,000 × g for 5 min and resuspended in 180 µl of
ATL buffer from the QIAamp tissue kit (Qiagen, Hilden, Germany). Subsequently, NAs were extracted with the QIAamp tissue kit, following the manufacturer's recommendations. NA samples were eluted with distilled water and adjusted to a final concentration of 1 µg/ml according to A260 values.
Analysis of AP-PCR bands and generation of specific primers.
In preliminary studies, genotyping of C. glabrata isolates
was performed by an optimized and standardized AP-PCR protocol, resulting in three major genotypes (3). AP-PCR with random primer AP50-1 (5'-GAT TCA GAC C-3') was done as
described previously, although with drastically prolonged ramp
times (7 min) (3, 8). Putative C. glabrata
species-specific bands (approximately 0.35, 1.8, and 2.8 kbp) (Fig.
1) were excised and NAs were extracted from agarose gel by using Ultrafree-DA (Millipore,
Bedford, Mass.). Subsequently, DNA was sequenced directly using
the Taq DyeDeoxy terminator cycle sequencing kit (Applied
Biosystems, Foster City, Calif.) and the ABIPRISM 310 genetic
analyzer automated sequencing system (Applied Biosystems) (data not
shown). From the derived sequence information, a number of putative
C. glabrata-specific primer pairs were designed by using
Primer Premier version 4.04 software (Premier Biosoft International,
Palo Alto, Calif.) and were tested for their applicability in PCR for
C. glabrata detection (data not shown). The primer pair
CG-R31-1 (5'-AAG AAG GCT GCC TGT TGT AAT G-3')-CG-R31-2
(5'-CAC TTA TCT AAA CAA CGG TGG C-3'), which was derived
from a fragment designated CGR31, was further studied. Using this
primer pair, a 978-bp product was amplified (Fig.
2).

View larger version (85K):
[in this window]
[in a new window]
|
FIG. 1.
Results of agarose gel electrophoresis of AP-PCR with
random primer AP50-1 demonstrating patterns of different C. glabrata genotypes compared with other Candida species.
Lane M, DNA molecular size marker (1-kb/100-bp DNA ladder); lane 1, C. glabrata genotype A; lane 2, C. glabrata genotype B; lane 3, C. glabrata genotype
C; lane 4, C. albicans; lane 5, C. guilliermondii; lane 6, C. kefyr; lane 7, C. krusei; lane 8, C. norvegensis; lane
9, C. parapsilosis; lane 10, C. tropicalis. Sizes are marked in kilobase pairs on the left.
|
|

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 2.
PCR-generated 978-bp product obtained with C. glabrata-specific primer pair. Lane M, DNA molecular size marker
(1-kb/100-bp DNA ladder); lane 1, C. glabrata genotype
A; lane 2, C. glabrata genotype B; lane 3, C. glabrata genotype C; lane 4, C. tropicalis; lane 5, C. krusei; lane 6, C. parapsilosis; lane 7, C. guilliermondii; lane 8, C. albicans; lane 9, C. kefyr; lane 10, C. inconspicua; lane
11, C. lusitaniae; lane 12, C. lambica;
lane 13, S. cerevisiae; lane 14, no DNA template. Sizes
are marked in base pairs on the left.
|
|
Analysis of 978-bp CGR31 fragment.
The 978-bp PCR product of
the CGR31 fragment was sequenced as described above. The NA
sequence alignment of the 978-bp fragment by FASTA program
searches of the EMBL Data Library showed 58.1% homology to a part of a
3.8-kb DNA fragment which contained, in addition to two unassigned open
reading frames (ORFs), the gene encoding a putative
mitochondrial ribosomal protein of Saccharomyces cerevisiae
designated MRP-L6p (12). The nucleotide sequence of the
978-bp CGR31 fragment enclosed an ORF, presumably beginning before the
start of the fragment and extending to base pair 226, which codes for a
polypeptide of 75 amino acids whose deduced amino acid sequence showed
84.0% identity to that of the S. cerevisiae ORF product
P32899. This ORF was found to be neighbored by MRP-L6
(12). Disruption of MRP-L6 led to the
phenotype of a mitochondrial translation-defective yeast mutant,
suggesting that the MRP-L6 gene is coding for an essential
component of yeast mitochondrial ribosomes (12).
C. glabrata-specific PCR of CGR31 fragment.
Amplification reactions of C. glabrata-specific PCR
using primers CG-R31-1 and CG-R31-2 were carried out in a volume of 100 µl of a PCR mixture containing 10 µM (each) dATP, dCTP, dGTP, and
dTTP and 1 µg of DNA template. The master mixture contained 10 mM
Tris-HCl (pH 8.3), 50 mM KCl, 1.5 mM MgCl2, 50 pmol of each primer, and 2.5 U of DNA polymerase. The amplification was performed in
an automated thermocycler with a hot bonnet (Hybaid, Teddington, United
Kingdom). The optimized thermal cycling conditions were 30 cycles of
denaturation at 95°C for 1 min (5 min for the first cycle), annealing
at 58°C for 1 min, and polymerization at 72°C for 2 min. Amplified
products (10 µl) were resolved by 2% agarose gel electrophoresis at
150 V for 1.5 h. The gel was stained with ethidium bromide and
exposed to UV light (254-nm wavelength) to visualize the amplified
products. To avoid possible contamination, all reactions were done as
described previously (19).
Sensitivity and specificity of C. glabrata-specific PCR.
A total of 173 yeast isolates,
including 95 reference and clinical isolates of C. glabrata as well as 78 isolates of other yeast species, were
studied (Tables 1 and
2). The clinical isolates were obtained from human
(n = 84) and animal (n = 9) specimens collected in different German and European medical centers
(3). Each of the 53 human C. glabrata
isolates was from a different subject. The remaining 40 human isolates
were from 13 patients and were obtained from diverse specimens or at
different times of isolation. In tests of the clinical and reference
strains of C. glabrata, the expected amplicon was
successfully generated from all human and animal C. glabrata isolates tested (Table 1). With regard to the three major
genotypes of C. glabrata, no differences in PCR
products were observed (Fig. 2). The primer pair amplified the
predicted PCR products in reaction mixtures with about 10 pg of total
DNA. To investigate the specificity of PCR for putative C. glabrata isolates, 66 isolates of 16 other Candida
species were tested (Table 2). Since C. glabrata is
specifically related to S. cerevisiae (2),
12 isolates of this species were included. Additionally, 14 mold
strains were encompassed. No PCR products were amplified when DNA
isolates from fungi other than C. glabrata were used as
templates (Fig. 2; Table 2).
Compared with species-specific structural genes, rRNA genes are
attractive targets for amplification-based detection assays,
since
these genes are present at a high copy number, thus increasing
the
sensitivity of the PCR (
15). Furthermore, rRNA
genes are
composed of regions of higher and lower evolutionary
conservation,
thereby enabling amplification at different taxonomic
levels.
Consequently, nuclear ribosomal genes have been widely used as
a target for detection of fungal microorganisms by molecular methods
(
13,
15,
20). Although mitochondrial ribosomal sequences
seem to offer the same diagnostic advantages, their use as diagnostic
targets is as yet more uncommon. Regarding fungal pathogens, several
PCR applications based on mitochondrial ribosomal gene sequences
have
been developed for
Pneumocystis carinii (
6,
10,
14).
Recently, the use of conserved and variable regions of
different
domains of mitochondrial small-subunit rRNA of
Agrocybe spp. was
proposed as a specific molecular marker
for differentiation of
Basidiomycota (
11). To
our knowledge, the present study reports
the first PCR application of a
mitochondrial ribosome sequence
as a target to identify one of the
medically important
Candida species.
As shown in our study, the selection and analysis of taxon-specific
bands within patterns of AP-PCR may offer an alternative
way to obtain
NA sequences which could be used to deduce specific
diagnostic primers
for conventional high-stringency PCR. In summary,
the newly described
PCR will facilitate rapid, sensitive, and
specific identification of
C. glabrata isolates. Since rapid detection
of putative
azole-resistant yeasts is of clinical importance,
further research is
desirable to apply this molecular approach
to other emerging yeasts and
to adjust it to direct PCR examination
of clinical
specimens.
Nucleotide sequence accession number.
For the sequence of the
978-bp PCR product of the CGR31 fragment, the GenBank accession number
AJ289782 has been assigned.
 |
ACKNOWLEDGMENTS |
We thank Elke Kruse, Brigitte Schuhen, and Michaela Brück for
excellent technical assistance.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Hospital and
Clinics, Institute of Medical Microbiology, University of
Münster, D-48149 Münster, Germany. Phone: (49) 251 83-55360. Fax: (49) 251 83-55350. E-mail:
kbecker{at}uni-muenster.de.
 |
REFERENCES |
| 1.
|
Barnett, J. A.,
R. W. Payne, and D. Yarrow.
1983.
Yeasts characteristics and identification.
Cambridge University Press, Cambridge, England.
|
| 2.
|
Barns, S. M.,
D. J. Lane,
M. L. Sogin,
C. Bibeau, and W. G. Weisburg.
1991.
Evolutionary relationships among pathogenic Candida species and relatives.
J. Bacteriol.
173:2250-2255[Abstract/Free Full Text].
|
| 3.
|
Becker, K.,
D. Badehorn,
S. Deiwick,
G. Peters, and W. Fegeler.
2000.
Molecular genotyping of Candida species with special respect to Candida (Torulopsis) glabrata strains by arbitrarily primed PCR.
J. Med. Microbiol.
49:575-581[Abstract/Free Full Text].
|
| 4.
|
Buchaille, L.,
A. M. Freydiere,
R. Guinet, and Y. Gille.
1998.
Evaluation of six commercial systems for identification of medically important yeasts.
Eur. J. Clin. Microbiol. Infect. Dis.
17:479-488[Medline].
|
| 5.
|
Daffonchio, D.,
S. Borin,
G. Frova,
R. Gallo,
E. Mori,
R. Fani, and C. Sorlini.
1999.
A randomly amplified polymorphic DNA marker specific for the Bacillus cereus group is diagnostic for Bacillus anthracis.
Appl. Environ. Microbiol.
65:1298-1303[Abstract/Free Full Text].
|
| 6.
|
De Luca, A.,
E. Tamburrini,
E. Ortona,
P. Mencarini,
P. Margutti,
A. Antinori,
E. Visconti, and A. Siracusano.
1995.
Variable efficiency of three primer pairs for the diagnosis of Pneumocystis carinii pneumonia by the polymerase chain reaction.
Mol. Cell. Probes
9:333-340[CrossRef][Medline].
|
| 7.
|
Do an, B.,
S. Asikainen, and H. Jousimies-Somer.
1999.
Evaluation of two commercial kits and arbitrarily primed PCR for identification and differentiation of Actinobacillus actinomycetemcomitans, Haemophilus aphrophilus, and Haemophilus paraphrophilus.
J. Clin. Microbiol.
37:742-747[Abstract/Free Full Text].
|
| 8.
|
Ellinghaus, P.,
D. Badehorn,
R. Blumer,
K. Becker, and U. Seedorf.
1999.
Increased efficiency of arbitrarily primed PCR by prolonged ramp times.
BioTechniques
26:626-628[Medline], 630.
|
| 9.
|
Ellis, M. E.,
H. Clink,
P. Ernst,
M. A. Halim,
A. Padmos,
D. Spence,
M. Kalin,
Q. S. Hussain,
J. Burnie, and W. Greer.
1994.
Controlled study of fluconazole in the prevention of fungal infections in neutropenic patients with haematological malignancies and bone marrow transplant recipients.
Eur. J. Clin. Microbiol. Infect. Dis.
13:3-11[CrossRef][Medline].
|
| 10.
|
Evans, R.,
A. W. Joss,
T. H. Pennington, and D. O. Ho-Yen.
1995.
The use of a nested polymerase chain reaction for detecting Pneumocystis carinii from lung and blood in rat and human infection.
J. Med. Microbiol.
42:209-213[Abstract/Free Full Text].
|
| 11.
|
Gonzalez, P., and J. Labarère.
1998.
Sequence and secondary structure of the mitochondrial small-subunit rRNA V4, V6, and V9 domains reveal highly species-specific variations within the genus Agrocybe.
Appl. Environ. Microbiol.
64:4149-4160[Abstract/Free Full Text].
|
| 12.
|
Harrer, R.,
S. Schwank,
H. J. Schüller, and E. Schweizer.
1993.
Molecular cloning and analysis of the nuclear gene MRP-L6 coding for a putative mitochondrial ribosomal protein from Saccharomyces cerevisiae.
Curr. Genet.
24:136-140[CrossRef][Medline].
|
| 13.
|
Haynes, K. A.,
T. J. Westerneng,
J. W. Fell, and W. Moens.
1995.
Rapid detection and identification of pathogenic fungi by polymerase chain reaction amplification of large subunit ribosomal DNA.
J. Med. Vet. Mycol.
33:319-325[Medline].
|
| 14.
|
Helweg-Larsen, J.,
J. S. Jensen,
T. Benfield,
U. G. Svendsen,
J. D. Lundgren, and B. Lundgren.
1998.
Diagnostic use of PCR for detection of Pneumocystis carinii in oral wash samples.
J. Clin. Microbiol.
36:2068-2072[Abstract/Free Full Text].
|
| 15.
|
Hopfer, R. L.,
P. Walden,
S. Setterquist, and W. E. Highsmith.
1993.
Detection and differentiation of fungi in clinical specimens using polymerase chain reaction (PCR) amplification and restriction enzyme analysis.
J. Med. Vet. Mycol.
31:65-75[Medline].
|
| 16.
|
Houang, E. T.,
K. C. Chu,
A. P. Koehler, and A. F. Cheng.
1997.
Use of CHROMagar Candida for genital specimens in the diagnostic laboratory.
J. Clin. Pathol.
50:563-565[Abstract/Free Full Text].
|
| 17.
|
Krcmery, V.
1999.
Torulopsis glabrata an emerging yeast pathogen in cancer patients.
Int. J. Antimicrob. Agents
11:1-6[CrossRef][Medline].
|
| 18.
|
Kurtzman, C. P., and J. W. Fell (ed.).
1997.
The yeasts: a taxonomic study, 4th ed.
Elsevier, Amsterdam, The Netherlands.
|
| 19.
|
Kwok, S., and R. Higuchi.
1989.
Avoiding false positives with PCR.
Nature
339:237-238[CrossRef][Medline].
|
| 20.
|
Makimura, K.,
S. Y. Murayama, and H. Yamaguchi.
1994.
Detection of a wide range of medically important fungi by the polymerase chain reaction.
J. Med. Microbiol.
40:358-364[Abstract/Free Full Text].
|
| 21.
|
Odds, F. C.
1996.
Epidemiological shifts in opportunistic and nosocomial Candida infections: mycological aspects.
Int. J. Antimirob. Agents
6:141-144.
|
| 22.
|
Rudney, J. D., and C. J. Larson.
1999.
Identification of oral mitis group streptococci by arbitrarily primed polymerase chain reaction.
Oral Microbiol. Immunol.
14:33-42[CrossRef][Medline].
|
| 23.
|
Wingard, J. R.
1995.
Importance of Candida species other than C. albicans as pathogens in oncology patients.
Clin. Infect. Dis.
20:115-125[Medline].
|
| 24.
|
Wingard, J. R.,
W. G. Merz,
M. G. Rinaldi,
C. B. Miller,
J. E. Karp, and R. Saral.
1993.
Association of Torulopsis glabrata infections with fluconazole prophylaxis in neutropenic bone marrow transplant patients.
Antimicrob. Agents Chemother.
37:1847-1849[Abstract/Free Full Text].
|
Journal of Clinical Microbiology, September 2001, p. 3356-3359, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3356-3359.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Becker, K., Almasri, A. S., von Eiff, C., Peters, G., Heilmann, C., Fegeler, W.
(2007). Systematic Survey of Nonspecific Agglutination by Candida spp. in Latex Assays. J. Clin. Microbiol.
45: 1315-1318
[Abstract]
[Full Text]